Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!
What is the Expected Growth Rate of the Primary Biliary Cholangitis Market from 2024 to 2033?
The primary biliary cholangitis market has seen substantial growth, with its value expected to rise from $0.87 billion in 2023 to $0.98 billion in 2024, growing at a CAGR of 12.1%. This expansion has been driven by increased awareness of the disease, higher healthcare expenditures globally, strategic partnerships within healthcare, patient advocacy, and government liver health initiatives.
The primary biliary cholangitis market is expected to grow rapidly, reaching $1.46 billion by 2028 at a CAGR of 10.4%. This growth will be driven by the expansion of biomarker research, global efforts in rare disease management, increased collaboration in clinical trials, patient-centric healthcare, and rising demand for liver transplants. Major trends include advancements in biomarker research, emphasis on non-invasive diagnostics, focus on immunomodulatory therapies, AI integration, patient-reported outcomes, telemedicine for patient management, and emerging therapies targeting fibrosis.
Claim Your Free Sample of the Global Primary Biliary Cholangitis Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=13520&type=smp
What Key Factors Are Fueling the Growth of the Primary Biliary Cholangitis Market?
The rise in smoking is expected to drive the growth of the primary biliary cholangitis market. Smoking, which involves inhaling and exhaling tobacco smoke, is a known risk factor for liver diseases, including PBC. As smoking rates increase, more people are likely to seek medical attention for liver-related conditions. For example, Statistics Canada reported in July 2023 that cigarette production in Canada increased by 2.2% from June 2023, with a 2.6% rise in cigarette sales in June, reaching 1.4 billion units compared to May. Therefore, the increase in smoking will contribute to the growth of the primary biliary cholangitis market.
What Are the Major Segments of the Primary Biliary Cholangitis Market?
1) By Treatment Type: Drugs, Liver Transplantation
2) By Diagnosis: Imaging Tests, Magnetic Resonance Elastography (MRE), Magnetic Resonance Cholangiopancreatography (MRCP), Ultrasound, Fibroscan, Blood Tests, Cholesterol Test, Antibody Tests, Liver Tests, Other Diagnoses
3) By End-Users: Specialty Clinics, Homecare, Other End-Users
What New Trends Are Transforming the Primary Biliary Cholangitis Market?
Companies in the primary biliary cholangitis (PBC) market are focused on developing specialized treatments, such as orphan drugs combining obeticholic acid (OCA) and bezafibrates, to gain market exclusivity. This combination, which received orphan drug designation in May 2023 from the FDA, aims to offer a more effective approach to managing PBC, potentially improving the quality of life for patients with this rare disease. For example, Intercept Pharmaceuticals, a U.S.-based biopharmaceutical company, received FDA approval for obeticholic acid (marketed as Ocaliva) as a treatment for PBC.
Order Now for Fast Delivery of Your Primary Biliary Cholangitis Market Report!
https://www.thebusinessresearchcompany.com/report/primary-biliary-cholangitis-global-market-report
Which Regions Are Driving Growth in the Primary Biliary Cholangitis Market?
North America was the largest region in the primary biliary cholangitis market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the primary biliary cholangitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The Primary Biliary Cholangitis Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the primary biliary cholangitis market, its market share, and analyzes key competitors along with their market positions.
The Table Of Content For The Primary Biliary Cholangitis Market Include
1. Primary Biliary Cholangitis Market Executive Summary
2. Primary Biliary Cholangitis Market Segments
3. Primary Biliary Cholangitis Market Size And Template Market Growth Rate
4. Key Primary Biliary Cholangitis Market Trends
5. Major Primary Biliary Cholangitis Market Drivers
……
25. Key Mergers And Acquisitions In The Primary Biliary Cholangitis Market
26. Top Primary Biliary Cholangitis Companies
27. Primary Biliary Cholangitis Market Opportunities And Strategies
28. Primary Biliary Cholangitis Market, Conclusions And Recommendations
29. Appendix
Discover Related Reports by The Business Research Company:
Gastroesophageal Reflux Disease (GERD) Global Market Report 2024
Migraine Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/migraine-global-market-report
Myelodysplastic Syndrome Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/myelodysplastic-syndrome-global-market-report
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
